USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: ST. CHARLES PHARMACEUTICALS
Address: 650 Poydras St, Suite 2830
New Orleans, LA 70130
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $620,381.00 7
SBIR Phase II $4,526,095.00 3
STTR Phase I $100,000.00 2
STTR Phase II $499,068.00 1

Award List:

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kenneth W. Narducy
Award Amount: $99,999.00
Abstract:
Not Available Increased activity in space, coupled with the advent of new materials and increasingly complicated metal working service requirements, forces the constant improvement of existing metal processing technologies. The Electric Propulsion Laboratory, Inc., has

ANALGESICS FOR CHRONIC PAIN TREATMENT IN THE ELDERLY

Award Year / Program / Phase: 2001 / STTR / Phase I
Agency: HHS
Research Institution: LOUISIANA STATE UNIVERSITY
Principal Investigator: Kenneth W. Narducy
Award Amount: $100,000.00
RI Contact: N/A
Abstract:
DESCRIPTION(adapted from applicant's abstract): Acetaminophen, a nonsteroidal anti-inflammatory drug (NSAID), is widely used for treatment of pain and/or fever in the elderly. This dual action is sometimes contraindicated. In many instances pain needs to be controlled without… More

DEVELOPMENT OF NOVEL THERAPEUTICS FOR POSTSURGICAL PAIN

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kenneth W. Narducy
Award Amount: $0.00
Abstract:
Acetaminophen and NSAIDs have been used routinely for treatment of pain and/or fever. This dual action is sometimes contraindicated. In many instances, pain needs to be controlled without masking symptomatic fever (e.g., during the postoperative period). These drugs can cause hepatotoxicity,… More

DEVELOPMENT OF NOVEL THERAPEUTICS FOR POSTSURGICAL PAIN

Award Year / Program / Phase: 2002 / SBIR / Phase II
Agency: HHS
Principal Investigator: Kenneth W. Narducy
Award Amount: $835,120.00
Abstract:
Acetaminophen and NSAIDs have been used routinely for treatment of pain and/or fever. This dual action is sometimes contraindicated. In many instances, pain needs to be controlled without masking symptomatic fever (e.g., during the postoperative period). These drugs can cause hepatotoxicity,… More

Development of SCP-1 to Treat Pain in the Elderly

Award Year / Program / Phase: 2003 / STTR / Phase I
Agency: HHS
Research Institution: LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS
Principal Investigator: Kenneth W. Narducy
Award Amount: $0.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): Acetaminophen is widely used for treatment of pain and/or fever in the elderly. This dual action is sometimes contraindicated. In many instances, pain needs to be controlled without masking the symptomatic fever (e.g., fever due to infection during the… More

Novel Drug Combinations for Treating Pain in the Elderly

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Anthony L. Vaccarino
Award Amount: $99,959.00
Abstract:
DESCRIPTION (provided by applicant): Combination analgesics, including acetaminophen with opioids, are used extensively for pain management in the elderly (and others). This is, in part, because these combinations can produce analgesia that is additive or synergistic, and the adverse effects… More

Development of SCP-1/opioid combinations for pain

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kenneth W. Narducy
Award Amount: $99,947.00
Abstract:
DESCRIPTION (provided by applicant): Combinations of acetaminophen with opioids (i.e., hydrocodone, codeine) are frequently prescribed for acute and chronic pain management. Combinations of analgesics with different mechanisms of action enhance analgesic efficacy while reducing the dose-dependent… More

Pain Relieving Properties of Analgesic Metabolites

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Anthony L. Vaccarino
Award Amount: $99,278.00
Abstract:
DESCRIPTION (provided by applicant): Acetaminophen is used extensively in the management of mild to moderate pain. Even so, acetaminophen can cause hepatotoxicty after ingestion of large doses or from chronic use of smaller doses, particularly in the elderly, when liver function is compromised, or… More

Novel Analgesics for the Treatment of Bone Cancer Pain

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Anthony L. Vaccarino
Award Amount: $109,305.00
Abstract:
DESCRIPTION (provided by applicant): Pain is the most prevalent symptom in cancer patients, and bone metastasis is one of the most common sources of cancer-related pain. In the 3-step guidelines established by the World Health Organization (WHO) non-opioid analgesics (acetaminophen and NSAIDs) are… More

Novel drug combinations for the management of pain

Award Year / Program / Phase: 2005 / SBIR / Phase II
Agency: HHS
Principal Investigator: Anthony L. Vaccarino
Award Amount: $789,210.00
Abstract:
DESCRIPTION (provided by applicant): The therapeutic use of some analgesic compounds is often limited because of potentially adverse and dangerous side effects. However, combinations of analgesics with different mechanisms of action could enhance analgesic efficacy (synergy) while reducing the… More

Development of Non-Narcotic Intravenous Analgesics

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kenneth W. Narducy
Award Amount: $111,893.00
Abstract:
DESCRIPTION (provided by applicant): Intravenous drug administration is often clinically desired over oral administration, particularly for patients who have difficulty taking an oral drug due to their disease or condition (eg, unconsciousness, anesthetize d). IV administration also produces a… More

Preclinical Development of SCP-123 for Neuropathic Pain

Award Year / Program / Phase: 2007 / SBIR / Phase II
Agency: HHS
Principal Investigator: Kenneth W. Narducy
Award Amount: $2,901,765.00
Abstract:
DESCRIPTION (provided by applicant): Chronically, medically resistant pain is one of the most significant health problems in our country and affects more than 50 million Americans. Neuropathic pain syndromes are for the most part resistant to traditional analgesic treatments with NSAIDs,… More